SS-31 / Elamipretide
Re-ignite the cellular power plants.
SC injection — 5–10 mg SC daily in 4–12 week cycles; typically given as daily subcutaneous injections
What It Is
SS-31 (Elamipretide) is a synthetic tetrapeptide that targets the inner mitochondrial membrane, binding to cardiolipin and improving electron transport chain efficiency. It is essentially a mitochondrial antioxidant and stabilizer.
Mechanism
In aging cells, SS-31 has been shown to restore redox balance, improve ATP production, and reduce reactive oxygen species. Animal studies are compelling: in old mice, 8 weeks of SS-31 reversed age-related mitochondrial dysfunction in muscle and heart, improving exercise tolerance and cardiac diastolic function. Long-term treatment increased healthy lifespan markers — essentially "youth-ifying" the metabolism of older animals. SS-31's effects may vary by sex: male subjects get a bigger boost in muscle endurance while females see more improvement in cognitive measures and body composition stability.
How Dr. Emer Uses It
Dr. Emer incorporates SS-31 in patients who have signs of mitochondrial burnout — e.g. overtrained athletes, individuals with chronic fatigue or fibromyalgia, or older patients with memory complaints (since brain mitochondria benefit too). It is given as daily subcutaneous injections (5–10 mg) in 4–12 week cycles. In the Emer Method RE:BIRTH™ tier, SS-31 serves to "re-ignite the cellular power plants" as patients undergo intensive regeneration. It pairs well with exercise protocols and NAD+ boosters.
Key Benefits
- ✓Targets the inner mitochondrial membrane to restore redox balance and ATP production
- ✓Reduces reactive oxygen species and mitochondrial oxidative damage
- ✓Reverses age-related mitochondrial dysfunction in muscle and heart
- ✓Improves exercise tolerance and cardiac diastolic function
- ✓Supports brain mitochondria — benefits cognitive function in older patients
- ✓Mitigates mitochondrial damage from cardiotoxic chemotherapy drugs
Pairs Well With
Used In Programs
Safety & Considerations
Human trials (e.g. in heart failure) showed SS-31 is generally safe, with some patients reporting mild headaches or injection site reactions. No serious adverse events attributed to the peptide have emerged. Still, monitor blood pressure and kidney function in long courses, given its vasodilatory and cellular effects. Being investigated clinically for heart failure, mitochondrial myopathies, and kidney disease.
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
